Precision BioSciences

In News

Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 - investor.precisionbiosciences.com

investor.precisionbiosciences.com - May 27, 2026

Precision BioSciences: Promising HBV Editing Evidence (NASDAQ:DTIL) - Seeking Alpha

Seeking Alpha - Aug 18, 2026

Precision BioSciences at H.C. Wainwright conference: two shots on goal By Investing.com - Investing.com Nigeria

Investing.com Nigeria - Sep 17, 2026

Precision BioSciences stock trades quietly amid lack of fresh catalysts - AD HOC NEWS

AD HOC NEWS - Sep 19, 2026

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones - Business Wire

Business Wire - Jul 27, 2026

Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? - Yahoo Finance

Yahoo Finance - Jul 08, 2026

Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results - simplywall.st

simplywall.st - Aug 09, 2026

Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026 - biospace.com

biospace.com - May 21, 2026

Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference - investor.precisionbiosciences.com

investor.precisionbiosciences.com - Feb 18, 2026

Index Expanding Market Visibility with Institutional Investors - Business Wire

Business Wire - Jun 29, 2026

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study - Yahoo Finance

Yahoo Finance - Aug 24, 2026

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Business Wire - Jul 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment